Home / Pharmaceuticals / Rx / Arthritis Treatment Agent / Disease-Modifying Antirheumatic Agent / Orencia® Abatacept / Maltose, Preservative Free 250 mg / 15 mL Injection Single Use Vial 15 mL00003218713
Picture of Orencia® Abatacept / Maltose, Preservative Free 250 mg / 15 mL Injection Single Use Vial 15 mL00003218713

Orencia® Abatacept / Maltose, Preservative Free 250 mg / 15 mL Injection Single Use Vial 15 mL00003218713

Orencia®-Abatacept--Maltose,-Preservative-Free-250-mg--15-mL-Injection-Single-Use-Vial-15-mL00003218713

SKU #

#1124666

MPN #

00003218713

Brand

Bristol-Myers Squibb

Stock

In Stock

Quantity

100

Features

ORRENCIA, VL 250MG

$1,412.74 USD

Product Specifications Product Usage Additional Information
Print
Attribute Name Attribute Value
McKesson # 1124666
Manufacturer # 00003218713
Brand Orencia®
Manufacturer Bristol-Myers Squibb
Application Disease-Modifying Antirheumatic Agent
Container Type Single Use Vial
Dosage Form Injection
Generic Drug Code 26306
Generic Drug Name Abatacept / Maltose, Preservative Free
NDC Number 00003218713
Product Dating McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires Refrigeration
Strength 250 mg / 15 mL
Type Intravenous
UNSPSC Code 51203801
Volume 15 mL
Compare Selected Items Email

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • ORENCIA® (abatacept) is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA